Status:
COMPLETED
Sleep Wake and Melatonin Pattern in Craniopharyngioma
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Glostrup University Hospital, Copenhagen
Conditions:
Sleep Disorders, Circadian Rhythm
Craniopharyngioma
Eligibility:
All Genders
18-70 years
Brief Summary
The hypothalamus is a part of the brain containing a number of nuclei with a variety of functions. It is central in the regulation of hormone secretion, sleep, and circadian functions. The suprachiasm...
Detailed Description
The hypothalamus is a part of the brain containing a number of nuclei with a variety of functions. It is central in the regulation of hormone secretion, sleep, and circadian functions. The suprachiasm...
Eligibility Criteria
Inclusion
- patients treated for former craniopharyngiomas
- aged 18-70 years.
Exclusion
- insufficient substitution of pituitary hormone deficiencies within six months prior to inclusion
- total blindness
- clinically significant liver or renal disease
- use of non-steroid anti-inflammatory drugs
- beta-receptor antagonists
- antidepressants that affect serotonin
- active cancer
- epileptic seizures
- working night-shift
- breast feeding
- pregnancy,
- alcohol or drug abuse
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01881854
Start Date
November 1 2011
End Date
September 1 2016
Last Update
February 23 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.